PortfoliosLab logo
MYO vs. EUDA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MYO and EUDA is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.0

Performance

MYO vs. EUDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Myomo, Inc. (MYO) and EUDA Health Holdings Limited (EUDA). The values are adjusted to include any dividend payments, if applicable.

-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%NovemberDecember2025FebruaryMarchApril
-35.03%
-60.31%
MYO
EUDA

Key characteristics

Sharpe Ratio

MYO:

0.40

EUDA:

1.05

Sortino Ratio

MYO:

1.45

EUDA:

1.84

Omega Ratio

MYO:

1.17

EUDA:

1.24

Calmar Ratio

MYO:

0.37

EUDA:

1.23

Martin Ratio

MYO:

1.62

EUDA:

4.34

Ulcer Index

MYO:

22.61%

EUDA:

23.38%

Daily Std Dev

MYO:

91.47%

EUDA:

96.99%

Max Drawdown

MYO:

-99.93%

EUDA:

-95.02%

Current Drawdown

MYO:

-99.16%

EUDA:

-61.97%

Fundamentals

Market Cap

MYO:

$167.78M

EUDA:

$142.30M

EPS

MYO:

-$0.16

EUDA:

-$0.62

PS Ratio

MYO:

5.15

EUDA:

37.33

PB Ratio

MYO:

6.73

EUDA:

0.00

Total Revenue (TTM)

MYO:

$28.80M

EUDA:

$954.02K

Gross Profit (TTM)

MYO:

$20.89M

EUDA:

$221.04K

EBITDA (TTM)

MYO:

-$2.22M

EUDA:

-$788.98K

Returns By Period

In the year-to-date period, MYO achieves a -24.84% return, which is significantly lower than EUDA's -14.41% return.


MYO

YTD

-24.84%

1M

-0.41%

6M

28.72%

1Y

41.11%

5Y*

3.49%

10Y*

N/A

EUDA

YTD

-14.41%

1M

4.64%

6M

-18.51%

1Y

95.41%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MYO vs. EUDA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MYO
The Risk-Adjusted Performance Rank of MYO is 7272
Overall Rank
The Sharpe Ratio Rank of MYO is 6868
Sharpe Ratio Rank
The Sortino Ratio Rank of MYO is 7777
Sortino Ratio Rank
The Omega Ratio Rank of MYO is 7272
Omega Ratio Rank
The Calmar Ratio Rank of MYO is 6969
Calmar Ratio Rank
The Martin Ratio Rank of MYO is 7171
Martin Ratio Rank

EUDA
The Risk-Adjusted Performance Rank of EUDA is 8585
Overall Rank
The Sharpe Ratio Rank of EUDA is 8686
Sharpe Ratio Rank
The Sortino Ratio Rank of EUDA is 8484
Sortino Ratio Rank
The Omega Ratio Rank of EUDA is 8282
Omega Ratio Rank
The Calmar Ratio Rank of EUDA is 8787
Calmar Ratio Rank
The Martin Ratio Rank of EUDA is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MYO vs. EUDA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Myomo, Inc. (MYO) and EUDA Health Holdings Limited (EUDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for MYO, currently valued at 0.40, compared to the broader market-2.00-1.000.001.002.003.00
MYO: 0.40
EUDA: 1.05
The chart of Sortino ratio for MYO, currently valued at 1.45, compared to the broader market-6.00-4.00-2.000.002.004.00
MYO: 1.45
EUDA: 1.84
The chart of Omega ratio for MYO, currently valued at 1.17, compared to the broader market0.501.001.502.00
MYO: 1.17
EUDA: 1.24
The chart of Calmar ratio for MYO, currently valued at 0.55, compared to the broader market0.001.002.003.004.005.00
MYO: 0.55
EUDA: 1.23
The chart of Martin ratio for MYO, currently valued at 1.62, compared to the broader market-5.000.005.0010.0015.0020.00
MYO: 1.62
EUDA: 4.34

The current MYO Sharpe Ratio is 0.40, which is lower than the EUDA Sharpe Ratio of 1.05. The chart below compares the historical Sharpe Ratios of MYO and EUDA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.007.00NovemberDecember2025FebruaryMarchApril
0.40
1.05
MYO
EUDA

Dividends

MYO vs. EUDA - Dividend Comparison

Neither MYO nor EUDA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MYO vs. EUDA - Drawdown Comparison

The maximum MYO drawdown since its inception was -99.93%, which is greater than EUDA's maximum drawdown of -95.02%. Use the drawdown chart below to compare losses from any high point for MYO and EUDA. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%NovemberDecember2025FebruaryMarchApril
-43.13%
-61.97%
MYO
EUDA

Volatility

MYO vs. EUDA - Volatility Comparison

Myomo, Inc. (MYO) and EUDA Health Holdings Limited (EUDA) have volatilities of 17.74% and 18.40%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%40.00%45.00%NovemberDecember2025FebruaryMarchApril
17.74%
18.40%
MYO
EUDA

Financials

MYO vs. EUDA - Financials Comparison

This section allows you to compare key financial metrics between Myomo, Inc. and EUDA Health Holdings Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items